JP2006527227A5 - - Google Patents

Download PDF

Info

Publication number
JP2006527227A5
JP2006527227A5 JP2006515870A JP2006515870A JP2006527227A5 JP 2006527227 A5 JP2006527227 A5 JP 2006527227A5 JP 2006515870 A JP2006515870 A JP 2006515870A JP 2006515870 A JP2006515870 A JP 2006515870A JP 2006527227 A5 JP2006527227 A5 JP 2006527227A5
Authority
JP
Japan
Prior art keywords
alkyl
group
oxo
substituted
benzothieno
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006515870A
Other languages
English (en)
Japanese (ja)
Other versions
JP4612628B2 (ja
JP2006527227A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2004/006231 external-priority patent/WO2004110459A1/en
Publication of JP2006527227A publication Critical patent/JP2006527227A/ja
Publication of JP2006527227A5 publication Critical patent/JP2006527227A5/ja
Application granted granted Critical
Publication of JP4612628B2 publication Critical patent/JP4612628B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006515870A 2003-06-10 2004-06-09 17−β−ヒドロキシステロイドデヒドロゲナーゼのインヒビターとしてのチオフェンピリミジノン Expired - Fee Related JP4612628B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47701703P 2003-06-10 2003-06-10
PCT/EP2004/006231 WO2004110459A1 (en) 2003-06-10 2004-06-09 Thiophenepyrimidinones as 17-beta-hydroxysteroid dehydrogenase inhibitors

Publications (3)

Publication Number Publication Date
JP2006527227A JP2006527227A (ja) 2006-11-30
JP2006527227A5 true JP2006527227A5 (cg-RX-API-DMAC7.html) 2007-07-26
JP4612628B2 JP4612628B2 (ja) 2011-01-12

Family

ID=33551663

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006515870A Expired - Fee Related JP4612628B2 (ja) 2003-06-10 2004-06-09 17−β−ヒドロキシステロイドデヒドロゲナーゼのインヒビターとしてのチオフェンピリミジノン

Country Status (17)

Country Link
US (3) US7754709B2 (cg-RX-API-DMAC7.html)
EP (1) EP1635840B1 (cg-RX-API-DMAC7.html)
JP (1) JP4612628B2 (cg-RX-API-DMAC7.html)
CN (1) CN100502876C (cg-RX-API-DMAC7.html)
AR (1) AR044649A1 (cg-RX-API-DMAC7.html)
AT (1) ATE401893T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004246791B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0411319A (cg-RX-API-DMAC7.html)
CA (1) CA2527591A1 (cg-RX-API-DMAC7.html)
DE (1) DE602004015287D1 (cg-RX-API-DMAC7.html)
DK (1) DK1635840T3 (cg-RX-API-DMAC7.html)
ES (1) ES2311156T3 (cg-RX-API-DMAC7.html)
PL (1) PL1635840T3 (cg-RX-API-DMAC7.html)
PT (1) PT1635840E (cg-RX-API-DMAC7.html)
SA (1) SA04250158B1 (cg-RX-API-DMAC7.html)
TW (1) TW200504078A (cg-RX-API-DMAC7.html)
WO (1) WO2004110459A1 (cg-RX-API-DMAC7.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7524853B2 (en) 2003-06-10 2009-04-28 Solvay Pharmaceuticals B.V. Compounds and their use in therapy
EP1802634A2 (en) * 2004-10-20 2007-07-04 Compass Pharmaceuticals LLC Thiophens and their use as anti-tumor agents
MX2007007051A (es) * 2004-12-13 2007-06-26 Solvay Pharm Gmbh Nuevos derivados de tiofenpirimidiona sustituida como inhibidores de la 17??-hidroxiesteroide deshidrogenasa.
GB0513702D0 (en) 2005-07-04 2005-08-10 Sterix Ltd Compound
WO2007096647A2 (en) * 2006-02-27 2007-08-30 Sterix Limited Diaryl compounds as non-steroidal inhibitors of 17-beta hydroxysteroid dehydrogenase and/or steroid sulphatase for the treatment of oestrogen-related diseases such as hormone dependent breast cancer
MX2008011127A (es) * 2006-03-02 2008-10-31 Astellas Pharma Inc INHIBIDOR DE 17ß HSD TIPO 5.
US8080540B2 (en) 2006-09-19 2011-12-20 Abbott Products Gmbh Therapeutically active triazoles and their use
US8288367B2 (en) 2006-11-30 2012-10-16 Solvay Pharmaceuticals Gmbh Substituted estratriene derivatives as 17BETA HSD inhibitors
DE102007015169A1 (de) 2007-03-27 2008-10-02 Universität des Saarlandes Campus Saarbrücken 17Beta-Hydroxysteroid-Dehydrogenase-Typ1-Inhibitoren zur Behandlung hormonabhängiger Erkrankungen
DE102007040243A1 (de) 2007-08-25 2009-02-26 Universität des Saarlandes 17Beta-Hydroxysteriod-Dehydrogenase Typ1 Inhibitoren zur Behandlung hormonabhängiger Erkrankungen
GB0722779D0 (en) 2007-11-20 2008-01-02 Sterix Ltd Compound
WO2009135581A2 (en) * 2008-05-05 2009-11-12 Merck Patent Gmbh Novel nip thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
WO2012025638A1 (en) 2010-08-27 2012-03-01 Universität des Saarlandes Selective 17beta-hydroxysteroid dehydrogenase type 1 inhibitors
WO2012119605A1 (en) * 2011-03-10 2012-09-13 Akar Yahya Ahmed Abdellhafeez Salem New disperse dye with potent anticancer activity
TW201512215A (zh) 2013-06-25 2015-04-01 Forendo Pharma Ltd 治療活性雌三烯噻唑衍生物
JP6456373B2 (ja) 2013-06-25 2019-01-23 フォレンド ファーマ リミテッド 17β−ヒドロキシステロイドデヒドロゲナーゼ タイプ1の阻害剤として治療活性のあるエストラトリエンチアゾール誘導体
AU2014300894A1 (en) 2013-06-25 2016-01-28 Forendo Pharma Ltd Therapeutically active 17-nitrogen substituted estratrienthiazole derivatives as inhibitors of 17.beta.-hydroxysteroid dehydrogenase
US9884839B2 (en) 2014-01-03 2018-02-06 Elexopharm Gmbh Inhibitors of 17Beta-hydroxysteroid dehydrogenases type 1 and type 2
WO2016042775A1 (en) * 2014-09-18 2016-03-24 Sunovion Pharmaceuticals Inc. Tricyclic derivative
WO2016102775A1 (en) 2014-12-23 2016-06-30 Forendo Pharma Ltd PRODRUGS OF 17β-HSD1 -INHIBITORS
US10413557B2 (en) 2014-12-23 2019-09-17 Forendo Pharma Ltd. Prodrugs of 17.BETA.-HSD1-inhibitors
CA3049980A1 (en) 2017-01-23 2018-07-26 Regeneron Pharmaceuticals, Inc. Hydroxysteroid 17-beta dehydrogenase 13 (hsd17b13) variants and uses thereof
CA3059348A1 (en) 2017-04-11 2018-10-18 Regeneron Pharmaceuticals, Inc. Assays for screening activity of modulators of members of the hydroxysteroid (17-beta) dehydrogenase (hsd17b) family
SG11201911776PA (en) 2017-06-08 2020-01-30 Forendo Pharma Ltd 15.beta.-[3-propanamido]-substituted estra-1,3,5(10)-trien-17-one compounds and their 17-oximes for use in inhibition of 17.beta.-hydroxysteroid dehydrogenases
AU2018348195B2 (en) 2017-10-11 2025-05-15 Regeneron Pharmaceuticals, Inc. Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation
MY207352A (en) 2018-03-21 2025-02-21 Regeneron Pharma 17-hydroxysteroid dehydrogenase type 13 (hsd17b13) irna compositions and methods of use thereof
US10285998B1 (en) 2018-04-04 2019-05-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
US12534728B2 (en) 2018-09-19 2026-01-27 Arrowhead Pharmaceuticals, Inc. RNAi agents for inhibiting expression of 17beta-HSD type 13 (HSD17B13), compositions thereof, and methods of use
CN109180702B (zh) * 2018-10-29 2021-11-30 四川大学 一种噻吩并嘧啶酮化合物及其用途
CA3122049C (en) 2018-12-05 2023-10-17 Forendo Pharma Ltd Estra-1,3,5(10)-triene compounds condensed in position 16(17) with a pyrazole ring as inhibitors of 17-hsd1
PH12022550846A1 (en) * 2019-10-15 2023-03-27 Boehringer Ingelheim Pharma Thienopyrimidones as trpa1 inhibitors
JP7612682B2 (ja) 2019-10-15 2025-01-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規なテトラゾール
JP7565457B2 (ja) 2021-04-14 2024-10-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング TRPA1阻害剤としての3H,4H-チエノ-[2,3-d]ピリミジン-4-オン誘導体

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4742271B1 (cg-RX-API-DMAC7.html) * 1968-06-20 1972-10-25
DE2411273A1 (de) * 1974-03-06 1975-09-18 Schering Ag Neue thieno eckige klammer auf 2,3-d eckige klammer zu pyrimidinone und verfahren zu ihrer herstellung
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
US5364847A (en) * 1989-03-10 1994-11-15 Endorecherche Inhibitors of sex steroid biosynthesis and methods for their production and use
US5597823A (en) * 1995-01-27 1997-01-28 Abbott Laboratories Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists
JP3783810B2 (ja) 1997-01-14 2006-06-07 第一製薬株式会社 新規ベンゾフラノン誘導体及びその製造方法
JPH10273467A (ja) 1997-01-29 1998-10-13 Snow Brand Milk Prod Co Ltd 新規テトラロン又はベンゾピラノン誘導体及びその製造方法
AU9001698A (en) 1997-09-11 1999-03-29 Snow Brand Milk Products Co., Ltd. Remedies for hormone-dependent diseases
MXPA00008868A (es) * 1998-03-11 2003-04-25 Endorech Inc Inhibidores de dihidrogenasa de 17 -hidroxiesteroide y metodos para su uso.
GB9816729D0 (en) 1998-08-01 1998-09-30 Hoechst Schering Agrevo Gmbh Substituted cyclohexylaminopyrimidines
GB9929302D0 (en) 1999-12-11 2000-02-02 Univ Cardiff Benzyl tetralins compositions and uses thereof
AU2001296961A1 (en) 2000-09-29 2002-04-08 Bayer Pharmaceuticals Corporation 17-beta-hydroxysteroid dehydrogenase-ii inhibitors
WO2003017974A1 (en) 2001-08-31 2003-03-06 Pantarhei Bioscience B.V. Method of treating benign gynaecological disorders and a pharmaceutical kit for use in such method
MY141661A (en) * 2001-09-06 2010-05-31 Schering Corp 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
US6750248B2 (en) * 2001-11-09 2004-06-15 National University Of Singapore Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof
FI20030393A7 (fi) 2003-03-14 2004-09-15 Molekyyliendokrinologian Tutkimusyksikkoe Menetelmiä, joilla voidaan ennustaa rintasyövän kehistyskulku ja yhdisteitä, joita voidaan käyttää sen ehkäisemiseksi tai hoitamiseksi
GB0324792D0 (en) * 2003-10-23 2003-11-26 Sterix Ltd Compound
AU2005247929B2 (en) * 2004-05-24 2010-03-11 Amgen Inc. Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1

Similar Documents

Publication Publication Date Title
ES2311156T3 (es) Tiofeno-pirimidinonas en calidad de inhibidores de 17-beta-hidroxiesteroide-deshidrogenasa.
EP1491543B1 (en) Intermediate compounds for the preparation of imidazo-pyridine derivates
Kamal et al. Design and synthesis of C-8 linked pyrrolobenzodiazepine–naphthalimide hybrids as anti-tumour agents
EP1070710A3 (en) Dithiolan derivatives, their preparation and their therapeutic effect
KR960703852A (ko) 이환상 테트라하이드로 피라졸로피리딘(bicyclic tetrahydro pyrazolopyridines)
PT1635839E (pt) Benzo[4,5]tieno[2,3-d]pirimidin-4-onas e sua utilização em terapia
CY1112997T1 (el) ΝΕΑ ΠΑΡΑΓΩΓΑ ΙΜΙΔΑΖΟ[1,5-α]ΠΥΡΙΔΙΝΩΝ, Η ΔΙΑΔΙΚΑΣIΑ ΠΑΡΑΣΚΕΥΗΣ ΤΟΥΣ ΚΑΙ ΟΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΑ ΠΕΡΙΕΧΟΥΝ
JP2002356472A5 (cg-RX-API-DMAC7.html)
MX2007000044A (es) Compuestos, composiciones y metodos de tetrahidroquinazolin-4(3h)- ona-relacionados y tetrahidropirido [2,3-d] pirimidin-4(3h)-ona- relacionados para su uso.
DE60139639D1 (de) Substituierte thiazolderivate mit 3-pyridylgruppen, verfahren zu deren herstellung und deren verwendung
CN110143974A (zh) 一类新型青蒿素衍生物、合成方法及其用途
NO20070837L (no) Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer.
JP2004527567A5 (cg-RX-API-DMAC7.html)
PL173738B1 (pl) Sposób wytwarzania pochodnych pirolo(2,3-d)pirymidyny
ATE429429T1 (de) Pharmazeutisches verfahren und damit hergestellte verbindungen
KR970003440A (ko) 삼환 5,6-디하이드로-9H-피라졸로[3,4-c]-1,2,4-트리아졸로[4,3-α]피리딘
Alagarsamy et al. Synthesis and pharmacological investigation of novel 1-substituted-4-phenyl-1, 2, 4-triazolo [4, 3-a] quinazolin-5 (4H)-ones as a new class of H1-antihistaminic agents
JP2001513567A (ja) カンプトテシン類似体及びその調製方法
WO2007080324A3 (fr) Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
FR2815345B1 (fr) Nouveaux derives de cyclobutene-dione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2012007619A1 (es) Proceso de obtención de derivados solubles en agua de 20(s)camptotecina como agentes antitumorales
JP2007045838A5 (cg-RX-API-DMAC7.html)
CN100408582C (zh) 高喜树碱类化合物及其制备方法和用途
AU2003273969A1 (en) Sulfonamide derivatives as antipsychotic agents
UY26111A1 (es) Derivados de ciclobuten-3, 4-diona, su preparación y su aplicación en terapéutica